Shaanxi Micot Pharmaceutical Technology (HKG:2335) said its H shares have been included in the eligible securities lists under the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, effective Monday, according to same-day Hong Kong bourse filing.
The inclusion allows eligible mainland Chinese investors to trade the company's shares through the Shanghai Stock Exchange and Shenzhen Stock Exchange.